Technical Data
D2800-13F
Dengue Virus, Type 2, Envelope (E)
Description:
Dengue infection is a major cause of morbidity in tropical and subtropical regions. It is a mosquito borne viral infection that may be asymptomatic or may cause undifferentiated fever, dengue fever, dengue haemorrhagic fever or dengue shock syndrome. The Dengue virus group consists of four closely related serotypes and belongs to the family Flaviviridae. Currently there is no vaccine or effective antiviral drugs to treat the infection.

Applications:
Suitable for use in Immunofluorescence. Other applications not tested.

Recommended Dilutions:
Immunofluorescence: 1:1000
Optimal dilutions to be determined by the researcher.

Storage and Stability:
Lyophilized powder may be stored at -20C. Stable for 12 months at -20C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20C. Reconstituted product is stable for 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
TypeIsotypeCloneGrade
MabIgG111C214Highly Purified
SizeStorageShippingSourceHost
500ug-20CBlue IceMouse
Concentration:
~1mg/ml (after reconstitution)
Immunogen:
Dengue infected cell lysate.
Purity:
Purified by Ion Exchange chromatography.
Form
Supplied as a lyophilized powder from PBS. No preservative added. Reconstitute with 500ul sterile ddH2O.
Specificity:
Recognizes Dengue Virus Type 2 envelope protein. Minimal crossreactivity with other Dengue subtypes.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.